All doses of Eli Lilly’s weight-loss vaccine, Zepbound, and diabetes drug, Mounjaro, are now available, according to the US Food and Drug Administration. Mounjaro has been on the FDA’s shortage list since late 2022, while Zepbound was added to the list in April this year.